Skip to main content
Livermore
Livermore
ZHEN

Qube Research & Technologies Ltd

SEC CIK
0001729829
Latest filing
Aug 14, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
520,267
Value
$24.9M
% of portfolio
<0.1%
Quarters held
15
Since Q1 2021
Holdings of NVO by Qube Research & Technologies Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026520,267$24.9M<0.1%+520,267NewHolders
Q1 20260$00.0%−171,416−100.0%Sold outHolders
Q4 2025171,416$8.72M<0.1%+171,416NewHolders
Q2 20250$00.0%−883,125−100.0%Sold outHolders
Q1 2025883,125$61.3M0.1%+27,983+3.3%AddedHolders
Q4 2024855,142$73.6M0.1%+192,899+29.1%AddedHolders
Q3 2024662,243$78.9M0.1%−64,399−8.9%ReducedHolders
Q2 2024726,642$103.7M0.2%+6,511+0.9%AddedHolders
Q1 2024720,131$92.5M0.2%+362,361+101.3%AddedHolders
Q4 2023357,770$37.0M0.1%−236,554−39.8%ReducedHolders
Q3 2023594,324$54.0M0.2%+288,252+94.2%AddedConverted for a 2-for-1 splitHolders
Q2 2023153,036$24.8M0.1%+153,036NewHolders
Q4 20220$00.0%−49,858−100.0%Sold outHolders
Q3 202249,858$4.97M<0.1%−57,898−53.7%ReducedHolders
Q2 2022107,756$12.0M0.1%+107,756NewHolders
Q1 20220$00.0%−2,554−100.0%Sold outHolders
Q4 20212,554$286.0K<0.1%−58,921−95.8%ReducedHolders
Q3 202161,475$5.90M0.1%+61,475NewHolders
Q2 20210$00.0%−36,359−100.0%Sold outHolders
Q1 202136,359$2.45M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.